14. Chronic inflammatory demyelinating polyneuropathy Clinical trials / Disease details
Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2004-002783-24-GB (EUCTR) | 25/05/2006 | 31/03/2006 | Prednisolone versus Dexamethasone in Chronic inflammatory demyelinating polyradiculoneuropathy Trial; PREDICT-trial - PREDICT trial | Prednisolone versus Dexamethasone in Chronic inflammatory demyelinating polyradiculoneuropathy Trial; PREDICT-trial - PREDICT trial | Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated disorder. CIDP is characterised by motor and/or sensory symptoms and signs in more than one limb, developing over at least two months. The disease runs a progressive, relapsing-remitting or monophasic course. The diagnosis of CIDP is based on the clinical, electrophysiological, cerebrospinal fluid features and, to a limited degree, on histopathology. | Product Name: dexamethasone Product Code: dexamethasone INN or Proposed INN: Dexamethasone Product Name: Prednisolone Product Code: Prednisolone INN or Proposed INN: Prednisolone Product Name: Prednisolone Product Code: Prednisolone INN or Proposed INN: Prednisolone Product Name: Prednisolone Product Code: Prednisolone INN or Proposed INN: Prednisolone Product Name: Prednisolone Product Code: Prednisolone INN or Proposed INN: Prednisolone Product Name: Prednisolone Product Code: Prednisolone INN or Proposed INN: Prednisolone | AMC Medical research BV | NULL | Not Recruiting | Female: yes Male: yes | 52 | United Kingdom |